Non-invasive methods for liver fibrosis prediction in hemochromatosis: One step beyond

World Journal of Hepatology

Volumn 2, Issue 7, 2010, Pages 251-255

  Castiella, Agustin ^a   Zapata, Eva ^a   Alústiza, José M ^b  

^a HOSPITAL DE MENDARO   (Spain)

^b Radiology Service Osatek Donostia   (Spain)

Author keywords

Hemochromatosis; Iron overload; Liver fibrosis; Magnetic resonance imaging; Non invasive; Ultrasound elastography

Indexed keywords

EID: 84861701537     PISSN: None     EISSN: 19485182     Source Type: Journal    
DOI: 10.4254/wjh.v2.i7.251     Document Type: Article

References (44)

1. Pietrangelo A. Hereditary hemochromatosis--a new look at an old disease. N Engl J Med 2004; 350: 2383-3297
2. Feder JN, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy DA, Basava A, Dormishian F, Domingo R Jr, Ellis MC, Fullan A, Hinton LM, Jones NL, Kimmel BE, Kronmal GS, Lauer P, Lee VK, Loeb DB, Mapa FA, McClelland E, Meyer NC, Mintier GA, Moeller N, Moore T, Morikang E, Prass CE, Quintana L, Starnes SM, Schatzman RC, Brunke KJ, Drayna DT, Risch NJ, Bacon BR, Wolff RK. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 1996; 13: 399-408
3. Gandon Y, Olivié D, Guyader D, Aubé C, Oberti F, Sebille V, Deugnier Y. Non-invasive assessment of hepatic iron stores by MRI. Lancet 2004; 363: 357-362
4. Castiella A, Alustiza JM, Artetxe J. Hereditary hemochromatosis. N Engl J Med 2004; 351: 1263-1264; author reply 1263-1264
5. Wood MJ, Skoien R, Powell LW. The global burden of iron overload. Hepatol Int 2009; 3: 434-444
6. Froehlich F, Lamy O, Fried M, Gonvers JJ. Practice and complications of liver biopsy. Results of a nationwide survey in Switzerland. Dig Dis Sci 1993; 38: 1480-1484
7. Thampanitchawong P, Piratvisuth T. Liver biopsy:complications and risk factors. World J Gastroenterol 1999; 5: 301-304
8. Bedossa P, Dargère D, Paradis V. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology 2003; 38: 1449-1457
9. de Sterke. Should we continue to perform liver biopsies in hereditary hemochromatosis (HH)? Open letter to all doctors involved in hereditary hemochromatosis. Update on January 5th 2010. Available from: URL: http://www.hemochromatosis.co.uk/liverbiopy/index.htm
10. Falize L, Guillygomarc'h A, Perrin M, Lainé F, Guyader D, Brissot P, Turlin B, Deugnier Y. Reversibility of hepatic fibrosis in treated genetic hemochromatosis: a study of 36 cases. Hepatology 2006; 44: 472-477
11. Clark P, Britton LJ, Powell LW. The diagnosis and management of hereditary haemochromatosis. Clin Biochem Rev 2010; 31: 3-8
12. Villeneuve JP, Bilodeau M, Lepage R, Côté J, Lefebvre M. Variability in hepatic iron concentration measurement from needle-biopsy specimens. J Hepatol 1996; 25: 172-177
13. Hübschner SG. Role of liver biopsy in disorders of iron metabolism. Diagnostic Histopathology 2008; 14: 577-585
14. Deugnier YM, Charalambous P, Le Quilleuc D, Turlin B, Searle J, Brissot P, Powell LW, Halliday JW. Preneoplastic significance of hepatic iron-free foci in genetic hemochromatosis: a study of 185 patients. Hepatology 1993; 18: 1363-1369
15. Guyader D, Gandon Y, Sapey T, Turlin B, Mendler MH, Brissot P, Deugnier Y. Magnetic resonance iron-free nodules in genetic hemochromatosis. Am J Gastroenterol 1999; 94: 1083-1086
16. Alústiza JM, Castiella A. Liver fat and iron at in-phase and opposed-phase MR imaging. Radiology 2008; 246: 641
17. Springer F, Machann J, Claussen CD, Schick F, Schwenzer NF. Liver fat content determined by magnetic resonance imaging and spectroscopy. World J Gastroenterol 2010; 16: 1560-1566
18. Marín Gabriel JC, Solís Herruzo JA. [Predicting liver fibrosis with non-invasive tests--a hope for the future]. Rev Esp Enferm Dig 2008; 100: 605-610
19. Guyader D, Jacquelinet C, Moirand R, Turlin B, Mendler MH, Chaperon J. Noninvasive prediction of fibrosis in C282Y homozygous hemochromatosis. Gastroenterology 1998; 115: 929-936
20. Bacon BR, Olynyk JK, Brunt EM, Britton RS, Wolff RK. HFE genotype in patients with hemochromatosis and other liver diseases. Ann Intern Med 1999; 130: 953-962
21. Beaton M, Guyader D, Deugnier Y, Moirand R, Chakrabarti S, Adams P. Noninvasive prediction of cirrhosis in C282Ylinked hemochromatosis. Hepatology 2002; 36: 673-678
22. Morrison ED, Brandhagen DJ, Phatak PD, Barton JC, Krawitt EL, El-Serag HB, Gordon SC, Galan MV, Tung BY, Ioannou GN, Kowdley KV. Serum ferritin level predicts advanced hepatic fibrosis among U.S. patients with phenotypic hemochromatosis. Ann Intern Med 2003; 138: 627-633
23. Olynyk JK, St Pierre TG, Britton RS, Brunt EM, Bacon BR. Duration of hepatic iron exposure increases the risk of significant fibrosis in hereditary hemochromatosis: a new role for magnetic resonance imaging. Am J Gastroenterol 2005; 100: 837-841
24. Sallie RW, Reed WD, Shilkin KB. Confirmation of the efficacy of hepatic tissue iron index in differentiating genetic haemochromatosis from alcoholic liver disease complicated by alcoholic haemosiderosis. Gut 1991; 32: 207-210
25. Castiella A, Zapata E, Otazua P, Fernández J, Alustiza JM, Ugarte M, Legasa L, Galardi A, Ugalde A, Barredo I, Arriola JA. [Utility of various non-invasive methods for fibrosis prediction among Basque Country patients with phenotypic hemochromatosis]. Rev Esp Enferm Dig 2008; 100: 611-614
26. Castiella A, Zapata E, Otazua P. Hemochromatosis: platelets and aspartate aminotransferase are useful high-degree fibrosis marker. Hepatology 2009; 49: 1781; author reply 1781-1782
27. Crawford DH, Murphy TL, Ramm LE, Fletcher LM, Clouston AD, Anderson GJ, Subramaniam VN, Powell LW, Ramm GA. Serum hyaluronic acid with serum ferritin accurately predicts cirrhosis and reduces the need for liver biopsy in C282Y hemochromatosis. Hepatology 2009; 49: 418-425
28. Beaton M, Adams PC. Assessment of silent liver fibrosis in hemochromatosis C282Y homozygotes with normal transaminase levels. Clin Gastroenterol Hepatol 2008; 6: 713-714
29. Olynyk JK, Hagan SE, Cullen DJ, Beilby J, Whittall DE. Evolution of untreated hereditary hemochromatosis in the Busselton population: a 17-year study. Mayo Clin Proc 2004; 79: 309-313
30. George DK, Ramm GA, Walker NI, Powell LW, Crawford DH. Elevated serum type IV collagen: a sensitive indicator of the presence of cirrhosis in haemochromatosis. J Hepatol 1999; 31: 47-52
31. Jensen PD, Heickandorff L, Helweg-Larsen HM, Jensen FT, Christensen T, Ellegaard J. Serum procollagen III peptide concentration in iron overload. Eur J Haematol 1996; 57: 157-164
32. Colombo M, Annoni G, Donato MF, Conte D, Martines D, Zaramella MG, Bianchi PA, Piperno A, Tiribelli C. Serum type III procollagen peptide in alcoholic liver disease and idiopathic hemochromatosis: its relationship to hepatic fibrosis, activity of the disease and iron overload. Hepatology 1985; 5: 475-479
33. Adhoute X, Foucher J, Laharie D, Terrebonne E, Vergniol J, Castéra L, Lovato B, Chanteloup E, Merrouche W, Couzigou P, de Lédinghen V. Diagnosis of liver fibrosis using FibroScan and other noninvasive methods in patients with hemochromatosis: a prospective study. Gastroenterol Clin Biol 2008; 32: 180-187
34. Bassett ML, Halliday JW, Powell LW. Value of hepatic iron measurements in early hemochromatosis and determination of the critical iron level associated with fibrosis. Hepatology 1986; 6: 24-29
35. Queiroz-Andrade M, Blasbalg R, Ortega CD, Rodstein MA, Baroni RH, Rocha MS, Cerri GG. MR imaging findings of iron overload. Radiographics 2009; 29: 1575-1589
36. Alústiza JM, Castiella A, De Juan MD, Emparanza JI, Artetxe J, Uranga M. Iron overload in the liver diagnostic and quantification. Eur J Radiol 2007; 61: 499-506
37. Wood JC. Magnetic resonance imaging measurement of iron overload. Curr Opin Hematol 2007; 14: 183-190
38. Tziomalos K, Perifanis V. Liver iron content determination by magnetic resonance imaging. World J Gastroenterol 2010; 16: 1587-1597
39. Pietrangelo A. Non-invasive assessment of hepatic iron overload: are we finally there? J Hepatol 2005; 42: 153-154
40. Pietrangelo A, Corradini E, Ferrara F, Vegetti A, De Jong G, Luca Abbati G, Paolo Arcuri P, Martinelli S, Cerofolini E. Magnetic resonance imaging to identify classic and nonclassic forms of ferroportin disease. Blood Cells Mol Dis 2006; 37: 192-196
41. Castiella A, Emparanza JI. External validation for fibrosis predicting index in hereditary hemochromatosis. Am J Gastroenterol 2005; 100: 2366-2367
42. Castera L, Forns X, Alberti A. Non-invasive evaluation of liver fibrosis using transient elastography. J Hepatol 2008; 48: 835-847
43. Castéra L, Foucher J, Bernard PH, Carvalho F, Allaix D, Merrouche W, Couzigou P, de Lédinghen V. Pitfalls of liver stiffness measurement: a 5-year prospective study of 13,369 examinations. Hepatology 2010; 51: 828-835
44. Huwart L, Sempoux C, Vicaut E, Salameh N, Annet L, Danse E, Peeters F, ter Beek LC, Rahier J, Sinkus R, Horsmans Y, Van Beers BE. Magnetic resonance elastography for the noninvasive staging of liver fibrosis. Gastroenterology 2008; 135: 32-40